Medicanna

Medicanna is an Israeli biopharmaceutical company focused on the development of advanced medical cannabis products and proprietary delivery technologies. The company specializes in creating standardized, pharmaceutical-grade cannabinoid formulations designed for precise dosing and improved therapeutic outcomes. Medicanna's lead technology involves a metered-dose inhaler (MDI) system that provides rapid systemic delivery of cannabinoids for indications such as chronic pain and sleep disorders. By applying rigorous pharmacological standards to cannabis-based medicine, the company aims to provide clinicians with reliable alternatives to traditional therapies. Medicanna's research and development efforts are centered on optimizing bioavailability and safety profiles for patients with unmet medical needs.